WallStreetZenWallStreetZen

NASDAQ: ZNTL
Zentalis Pharmaceuticals Inc Stock Ownership - Who owns Zentalis Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Zentalis Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Walters Group10% Owner2025-12-316,459,973$1.20
$7.75MBuy
Matrix Capital Management Company LP10% Owner2025-12-157,500,000$1.33
$9.98MSell
Scott Dunseth MyersDirector2025-04-3021,000$1.40
$29.38kBuy
Ingmar BrunsChief Medical Officer2025-02-0620,000$2.28
$45.66kBuy
Mark LacknerChief Scientific Officer2025-02-0314,368$1.71
$24.60kSell
Andrea PaulChief Legal Officer2025-02-0313,230$1.71
$22.65kSell
Vincent VultaggioPAO and Interim PFO2025-02-032,615$1.71
$4.48kSell
Jan SkvarkaDirector2025-01-3160,000$1.72
$103.44kBuy
Luke Nathaniel WalkerDirector2025-01-3114,200$1.76
$24.96kBuy
Julia Marie EastlandCEO President2025-01-3128,500$1.73
$49.33kBuy

1 of 1

ZNTL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ZNTL insiders and whales buy or sell their stock.

ZNTL Shareholders

What type of owners hold Zentalis Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Matrix Capital Management Company LP19.32%13,959,973$40.90MInstitution
Walters Group9.76%7,050,000$20.66MInsider
Matrix Capital Management Company LP8.94%6,459,973$18.93MInsider
Viking Global Investors LP5.46%3,943,284$11.55MInsider
David E. Goel5.29%3,821,739$11.20MInsider
Anthony Y. Sun5.23%3,780,043$11.08MInsider
Vanguard Group Inc4.02%2,904,400$8.51MInstitution
Acadian Asset Management LLC3.94%2,845,152$8.34MInstitution
Renaissance Technologies LLC3.22%2,325,355$6.81MInstitution
Citadel Advisors LLC2.88%2,077,290$6.09MInstitution

1 of 3

ZNTL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ZNTL62.97%37.03%Net SellingNet Selling
SRZN24.20%75.80%Net BuyingNet Buying
IRD5.79%94.21%Net SellingNet Selling
HUMA24.49%16.42%Net Selling
CGEN13.31%0.00%
View Top Biotech Stocks

Zentalis Pharmaceuticals Stock Ownership FAQ

Who owns Zentalis Pharmaceuticals?

Zentalis Pharmaceuticals (NASDAQ: ZNTL) is owned by 73.03% institutional shareholders, 42.96% Zentalis Pharmaceuticals insiders, and 0.00% retail investors. Walters Group is the largest individual Zentalis Pharmaceuticals shareholder, owning 7.05M shares representing 9.76% of the company. Walters Group's Zentalis Pharmaceuticals shares are currently valued at $18.05M.

If you're new to stock investing, here's how to buy Zentalis Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.